# Jingjing Qu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jingjing-qu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,607 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 21 |
| i10-index | 37 |
| Last Known Institution | First People's Hospital of Yuhang District |
| OpenAlex ID | https://openalex.org/A5069432515 |
| ORCID iD | 0000-0002-8079-4722 |
| Works | 109 |

## Researcher papers

- [The multi-functional roles of menstrual blood-derived stem cells in regenerative medicine](https://scholariq.org/papers/the-multi-functional-roles-of-menstrual-blood-derived-stem-cells-in-regenerative/)
- [An atlas of DNA methylomes in porcine adipose and muscle tissues](https://scholariq.org/papers/an-atlas-of-dna-methylomes-in-porcine-adipose-and-muscle-tissues/)
- [Recent developments in the role of reactive oxygen species in allergic asthma](https://scholariq.org/papers/recent-developments-in-the-role-of-reactive-oxygen-species-in-allergic-asthma/)
- [Menstrual blood-derived stem cells: toward therapeutic mechanisms, novel strategies, and future perspectives in the treatment of diseases](https://scholariq.org/papers/menstrual-blood-derived-stem-cells-toward-therapeutic-mechanisms-novel/)
- [Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy](https://scholariq.org/papers/tumor-organoids-synergistic-applications-current-challenges-and-future-prospects/)
- [Chimeric antigen receptor (CAR)-T-cell therapy in non-small-cell lung cancer (NSCLC): current status and future perspectives](https://scholariq.org/papers/chimeric-antigen-receptor-car-t-cell-therapy-in-non-small-cell-lung-cancer-nsclc/)
- [Evaluation of the safety and efficacy of using human menstrual blood‐derived mesenchymal stromal cells in treating severe and critically ill COVID‐19 patients: An exploratory clinical trial](https://scholariq.org/papers/evaluation-of-the-safety-and-efficacy-of-using-human-menstrual-blood-derived/)
- [Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19](https://scholariq.org/papers/clinical-study-using-mesenchymal-stem-cells-for-the-treatment-of-patients-with/)
- [Small extracellular vesicles from menstrual blood-derived mesenchymal stem cells (MenSCs) as a novel therapeutic impetus in regenerative medicine](https://scholariq.org/papers/small-extracellular-vesicles-from-menstrual-blood-derived-mesenchymal-stem-cells/)
- [Competing endogenous RNA in cancer: a new pattern of gene expression regulation.](https://scholariq.org/papers/competing-endogenous-rna-in-cancer-a-new-pattern-of-gene-expression-regulation/)
- [The clinicopathologic of pulmonary adenocarcinoma transformation to small cell lung cancer](https://scholariq.org/papers/the-clinicopathologic-of-pulmonary-adenocarcinoma-transformation-to-small-cell/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Mesenchymal stem cell research](https://scholariq.org/topics/mesenchymal-stem-cell-research/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

## Researcher university

- [First People's Hospital of Yuhang District](https://scholariq.org/institutions/first-people-s-hospital-of-yuhang-district/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.